Growth Metrics

Bio-Techne (TECH) Total Liabilities (2009 - 2026)

Bio-Techne's quarterly Total Liabilities came in at $465.3 million in Q1 2026, down 25.7% year-on-year from $626.2 million in Q1 2025, and down 9.07% quarter-over-quarter from $511.7 million in Q4 2025.

Bio-Techne has reported Total Liabilities for 18 years, with the latest figure at $465.3 million in Q1 2026.

  • For the quarter ending Q1 2026, Total Liabilities fell 25.7% year-over-year to $465.3 million; the trailing twelve-month figure through Mar 2026 stood at $465.3 million (down 25.7% YoY), and the FY2025 full-year result was $639.1 million, up 0.64% from the prior year.
  • Total Liabilities for Q1 2026 stood at $465.3 million, down from $511.7 million in the prior quarter.
  • The five-year high for Total Liabilities was $767.2 million in Q4 2023, with the low at $465.3 million in Q1 2026.
  • Average Total Liabilities over 5 years is $621.0 million, with a median of $599.6 million recorded in 2022.
  • Year-over-year, Total Liabilities surged 43.05% in 2023 and dropped 25.7% in 2026.
  • Tracing TECH's Total Liabilities over 5 years: stood at $536.3 million in 2022, then surged by 43.05% to $767.2 million in 2023, then fell by 22.84% to $591.9 million in 2024, then dropped by 13.55% to $511.7 million in 2025, then fell by 9.07% to $465.3 million in 2026.
  • The last three Total Liabilities figures came in at $465.3 million (Q1 2026), $511.7 million (Q4 2025), and $560.3 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 16.35 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 1.74 Mn
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 731.60 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 177.22 Mn
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 19.51 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 7.12 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - 10.44 Mn
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 9.45 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 4.05 Bn
10 Bio-Techne 7.92 Bn 7.71 Bn 208.29 Mn 465.30 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 465.30 Mn
Dec 31, 2025 511.71 Mn
Sep 30, 2025 560.33 Mn
Jun 30, 2025 639.06 Mn
Mar 31, 2025 626.23 Mn
Dec 31, 2024 591.93 Mn
Sep 30, 2024 597.37 Mn
Jun 30, 2024 635.02 Mn
Mar 31, 2024 706.80 Mn
Dec 31, 2023 767.19 Mn
Sep 30, 2023 757.61 Mn
Jun 30, 2023 672.18 Mn
Mar 31, 2023 710.01 Mn
Dec 31, 2022 536.30 Mn
Sep 30, 2022 599.57 Mn
Jun 30, 2022 593.79 Mn
Mar 31, 2022 586.57 Mn
Dec 31, 2021 602.32 Mn
Sep 30, 2021 623.23 Mn
Jun 30, 2021 691.72 Mn
Mar 31, 2021 536.70 Mn
Dec 31, 2020 537.01 Mn
Sep 30, 2020 613.81 Mn
Jun 30, 2020 646.40 Mn
Mar 31, 2020 707.75 Mn
Dec 31, 2019 675.07 Mn
Sep 30, 2019 750.80 Mn
Jun 30, 2019 718.82 Mn
Mar 31, 2019 726.35 Mn
Dec 31, 2018 748.41 Mn
Sep 30, 2018 762.73 Mn
Jun 30, 2018 514.14 Mn
Mar 31, 2018 559.52 Mn
Dec 31, 2017 557.60 Mn
Sep 30, 2017 567.30 Mn
Jun 30, 2017 608.59 Mn
Mar 31, 2017 625.51 Mn
Dec 31, 2016 629.45 Mn
Sep 30, 2016 622.11 Mn
Jun 30, 2016 250.30 Mn
Mar 31, 2016 268.96 Mn
Dec 31, 2015 277.11 Mn
Sep 30, 2015 290.37 Mn
Jun 30, 2015 216.43 Mn
Mar 31, 2015 284.24 Mn
Dec 31, 2014 298.32 Mn
Sep 30, 2014 224.85 Mn
Jun 30, 2014 67.23 Mn
Mar 31, 2014 53.53 Mn
Dec 31, 2013 53.64 Mn
Sep 30, 2013 52.53 Mn
Jun 30, 2013 40.56 Mn
Mar 31, 2013 40.78 Mn
Dec 31, 2012 30.01 Mn
Sep 30, 2012 32.02 Mn
Jun 30, 2012 44.88 Mn
Mar 31, 2012 39.54 Mn
Dec 31, 2011 26.74 Mn
Sep 30, 2011 39.08 Mn
Jun 30, 2011 31.55 Mn
Mar 31, 2011 16.54 Mn
Dec 31, 2010 13.67 Mn
Sep 30, 2010 16.06 Mn
Jun 30, 2010 17.02 Mn
Jun 30, 2009 15.52 Mn